4.5 Article

Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries

Journal

INTERNATIONAL PSYCHOGERIATRICS
Volume 23, Issue 9, Pages 1520-1525

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1041610211000445

Keywords

antipsychotic; antidepressant; hypnotic; anxiolytic; acetylcholinesterase inhibitors; memantine; residential care; dosage

Funding

  1. Janssen-Cilag
  2. Astra-Zeneca
  3. Organon
  4. SmithKline Beecham
  5. Pharmacia
  6. Wyeth
  7. Pfizer
  8. Novartis
  9. Roche
  10. Lundbeck
  11. Janssen-Cilag Australia

Ask authors/readers for more resources

Background: This study aimed to explore changes in patterns of use of psychotropic medication in Sydney nursing homes over recent years, and to compare current usage rates with those reported from other countries. Methods: Data were obtained from 44 of the 48 nursing homes in a central Sydney health area. Researchers noted details from medication cards concerning residents' age, gender and all currently prescribed drugs, checking whether medication had been given as prescribed. Frequency of administration of as required drugs in the previous four weeks was noted. Results: The pattern of use of psychotropic medication changed considerably between 1993 and 2009. The number of residents taking regularly administered antipsychotics increased by 24% during 1998-2009, though mean dosages decreased. In 2009, fewer residents took hypnotic and/or anxiolytic medications than in the 1990s, and fewer than in countries from which equivalent data have been reported. Antidepressant use increased over the 16 years but only to 25.6%. Only 3% of residents in Sydney nursing homes in 2009 took cognition-enhancing drugs. Conclusions: Compared to other countries, rates of use of hypnotic, anxiolytic and antidepressant medication in Sydney nursing homes are low. Benefits and disadvantages of these differences merit analysis. Antipsychotic medications were administered to similar percentages of survey residents in 1993 and 2009, but at lower mean dosages in 2009 compared to previous surveys, and with a change to using mainly atypical antipsychotic drugs. Compared to various other countries, cognition-enhancing and antidepressant medications are administered to proportionally fewer residents in Sydney nursing homes. Outcome analysis regarding the use and benefits of such drugs in nursing homes is desirable.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available